Actinium Pharmaceuticals, Inc. (ATNM)

USD 1.16

(-4.92%)

Gross Profit Summary of Actinium Pharmaceuticals, Inc.

  • Actinium Pharmaceuticals, Inc.'s latest annual gross profit in 2023 was -709 Thousand USD , down -314.2% from previous year.
  • Actinium Pharmaceuticals, Inc.'s latest quarterly gross profit in 2024 Q2 was -189 Thousand USD , up 12.5% from previous quarter.
  • Actinium Pharmaceuticals, Inc. reported a annual gross profit of 331 Thousand USD in annual gross profit 2022, down -46.61% from previous year.
  • Actinium Pharmaceuticals, Inc. reported a annual gross profit of 620 Thousand USD in annual gross profit 2021, up 238.7% from previous year.
  • Actinium Pharmaceuticals, Inc. reported a quarterly gross profit of -216 Thousand USD for 2024 Q1, down -83.05% from previous quarter.
  • Actinium Pharmaceuticals, Inc. reported a quarterly gross profit of -709 Thousand USD for 2023 FY, down -314.2% from previous quarter.

Annual Gross Profit Chart of Actinium Pharmaceuticals, Inc. (2023 - 2006)

Historical Annual Gross Profit of Actinium Pharmaceuticals, Inc. (2023 - 2006)

Year Gross Profit Gross Profit Growth
2023 -709 Thousand USD -314.2%
2022 331 Thousand USD -46.61%
2021 620 Thousand USD 238.7%
2020 -447 Thousand USD -6.41%
2019 -420.08 Thousand USD -728.23%
2018 -50.72 Thousand USD 9.33%
2017 -55.93 Thousand USD 27.84%
2016 -77.52 Thousand USD -45.0%
2015 -53.46 Thousand USD 0.0%
2014 - USD 100.0%
2013 -4122.00 USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Gross Profit Comparison of Actinium Pharmaceuticals, Inc.

Name Gross Profit Gross Profit Difference
AIM ImmunoTech Inc. 160 Thousand USD 543.125%
Ampio Pharmaceuticals, Inc. -250 Thousand USD -183.6%
Armata Pharmaceuticals, Inc. -29.24 Million USD 97.575%
Azitra, Inc. 260.45 Thousand USD 372.22%
Can-Fite BioPharma Ltd. 743 Thousand USD 195.424%
Chromocell Therapeutics Corporation -2.57 Million USD 72.513%
Calidi Biotherapeutics, Inc. -1.25 Million USD 43.551%
CEL-SCI Corporation -3.95 Million USD 82.088%
iBio, Inc. -1.02 Million USD 30.829%
Lineage Cell Therapeutics, Inc. 8.27 Million USD 108.569%
MAIA Biotechnology, Inc. - USD Infinity%
Matinas BioPharma Holdings, Inc. -13.39 Million USD 94.706%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD -494.325%
NovaBay Pharmaceuticals, Inc. 7.89 Million USD 108.98%
NanoViricides, Inc. -759.01 Thousand USD 6.589%
Oragenics, Inc. -15.45 Million USD 95.412%
BiomX Inc. -1.22 Million USD 42.264%
BiomX Inc. -1.22 Million USD 42.264%
Protalix BioTherapeutics, Inc. 42.51 Million USD 101.668%
Palatin Technologies, Inc. 4.39 Million USD 116.141%
Scorpius Holdings, Inc. -2.21 Million USD 68.011%